Literature DB >> 35760378

Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination.

Josef Finsterer1, Fulvio A Scorza2.   

Abstract

Entities:  

Keywords:  Adverse reaction; COVID-19; Rhabdomyolysis; SARS-CoV-2; Side effect; Vaccination

Mesh:

Substances:

Year:  2022        PMID: 35760378      PMCID: PMC9233865          DOI: 10.1016/j.ijid.2022.06.034

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   12.074


× No keyword cloud information.
We read with interest the article by Kamura et al. about a 57-year-old, previously healthy male patient, who presented with leg pain 2 weeks after the first dose of the Moderna vaccine (Kamura ). Four weeks after the vaccination, he was diagnosed with rhabdomyolysis upon the clinical presentation (muscle pain), elevated creatine-kinase (maximal value 74,804 U/l [n, 60-287 U/l]), and the muscle magnetic resonance imaging (MRI) (Kamura ). During the following course, the patient additionally developed multiorgan infarctions and, finally, died despite intensive diagnostic and therapeutic approaches (Kamura ). The study is interesting but raises concerns that should be discussed. The main shortcoming of the study is that an acute SARS-CoV-2 infection had not been ruled out by polymerase chain reaction. Although SARS-CoV-2 infections can be complicated by rhabdomyolysis (Lamzouri ), it is crucial to rule out an acute SARS-CoV-2 infection in the index patient. Other causes of rhabdomyolysis that were not appropriately ruled out are hereditary neuromuscular disorder, seizures, food (mushrooms, coturnism), histiocytosis, insect bite, electrical shock, trauma, intoxication, or illicit drugs (Stanely ). To document myositis as the cause of rhabdomyolysis on muscle MRI, it is crucial to administer gadolinium. However, only a T2-image without contrast medium was presented (Kamura ). Therefore, we should be informed about the results of muscle MRI with contrast medium. Because infraction can be also embolic and because endocarditis or myocarditis have been reported as a complication of SARS-CoV-2 vaccinations (Aikawa ; Tiwari ), it is essential to know whether endocarditis and myocarditis were appropriately ruled out by echocardiography or even right ventricular myocardial biopsy or by cardiac MRI with contrast medium. In addition, we should be informed if ever during hospitalization or before hospitalization, atrial fibrillation had been recorded. The D-dimer was elevated (Kamura ); therefore, we should be informed if this was attributed to an ongoing infectious disease or due to vein occlusions. Particularly, we should know whether venous sinus thrombosis, portal vein thrombosis, pulmonary embolism, mesenteric vein thrombosis, or thrombosis of the jugular veins had been appropriately ruled out. Muscle biopsy of the quadriceps muscle revealed slight rhabdomyolysis, which was not seen on muscle MRI. Which is the reason for this discrepancy? Overall, the interesting study has some limitations and inconsistencies that call the results and their interpretation into question. Addressing these limitations could further strengthen and reinforce the statement of the study. Rhabdomyolysis requires extensive workup to uncover the underlying cause and to prevent recurrence.

Conflicts of interest

The authors have no competing interests to declare.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Ethical approval

The work has been approved by the institutional review board.

Availability of data

All data are available from the corresponding author.

Author contributions

JF: design, literature search, discussion, first draft, critical comments, and final approval; FS: literature search, discussion, critical comments, and final approval.
  4 in total

1.  Hyper-eosinophilic syndrome with myocarditis after inactivated SARS-CoV-2 vaccination - a case study.

Authors:  Ashutosh Tiwari; Gaurav Karna; Sankha Shubhra Chakrabarti; Prasan Kumar Panda; Upinder Kaur
Journal:  Curr Drug Saf       Date:  2022-05-09

2.  Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: A case report.

Authors:  Yuya Kamura; Toshiki Terao; Satoshi Akao; Yumi Kono; Koichi Honma; Kosei Matsue
Journal:  Int J Infect Dis       Date:  2022-02-18       Impact factor: 12.074

3.  Non-infectious endocarditis and myocarditis after COVID-19 mRNA vaccination.

Authors:  Tadao Aikawa; Jiro Ogino; Yuichi Kita; Naohiro Funayama; Noriko Oyama-Manabe
Journal:  Eur Heart J Case Rep       Date:  2022-01-03

4.  SARS-CoV-2 infection presenting as rhabdomyolysis: case report and review.

Authors:  Oussama Lamzouri; Amine Bouchlarhem; Leila Haddar; Ghizlane Elaidouni; Ounci Es-Saad; Houssam Bkiyar; Brahim Housni
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.